Regional
Norton Sound Health Corporation
The current listed document is more than 24 months old and may be outdated.
Drugs and doses23
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine5
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | page 151 |
| SVT | adult | 6 mg | IV | not captured | standing | pages 44, 47, 151 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 44, 47, 151 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | pages 18, 19, 153 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | pages 18, 19, 153 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 18, 56, 82, 84, 88, 153 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 18, 56, 82, 84, 88, 153 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | pages 25, 56, 57, 153 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | pages 25, 56, 57, 153 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | pages 40, 48, 154 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | pages 44, 154 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | pages 44, 154 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 28, 30, 154 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 28, 30, 154 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 28, 30, 154 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 28, 30, 154 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 36, 37, 155 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 32, 34, 156 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 32, 34, 156 |
| Organophosphate poisoning | adult | 2–6 mg | IV | not captured | standing | pages 80, 156 |
D–F Dextrose, Diphenhydramine, Epinephrine, Fentanyl4
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 16, 20, 90, 92, 94, 96, 157 |
| Hypoglycemia | peds | 2–4 mL/kg | IV/IO | not captured | standing | pages 16, 20, 90, 92, 94, 96, 157 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 16, 20, 90, 92, 94, 96, 157 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 18, 19, 159 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | pages 18, 19, 159 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | page 159 |
| Dystonic reaction | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Nausea / vomiting | adult | 50 mg | IV/IO/IM | not captured | standing | page 159 |
| Nausea / vomiting | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Other | adult | 50 mg | IV/IO/IM | not captured | standing | page 159 |
| Other | adult | 50 mg | IV/IO/IM | not captured | standing | pages 20, 21, 159, 216 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | pages 20, 21, 159, 216 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 18, 19, 160, 161 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 18, 19, 160, 161 |
| Asthma / bronchospasm | adult | 0.3 mg | SQ | not captured | standing | pages 82, 84, 160, 161 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | SQ | not captured | standing | pages 82, 84, 160, 161 |
| Bradycardia | adult | 0.5 mL | IV/IO | not captured | standing | pages 32, 34, 160, 161 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 32, 34, 160, 161 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 24, 25, 26, 27, 28, 160, 161 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 24, 25, 26, 27, 28, 160, 161 |
| Other | adult | 0.1–0.25 mg | IV/IO | not captured | standing | pages 18, 19, 160, 161 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 18, 19, 160, 161 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 mcg/kg | IN | not captured | standing | pages 14, 36, 50, 54, 78, 102, 110, 112, 114, 118 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO | not captured | standing | pages 14, 36, 50, 54, 78, 102, 110, 112, 114, 118 |
| Mild to moderate pain | peds | 1–2 mcg/kg | IV/IO | not captured | standing | pages 14, 36, 50, 54, 78, 102, 110, 112, 114, 118 |
| Mild to moderate pain | peds | 1–2 mcg/kg | IN | not captured | standing | pages 14, 36, 50, 54, 78, 102, 110, 112, 114, 118 |
G–L Glucagon, Ipratropium, Ketamine, Lidocaine, Lorazepam5
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV | not captured | standing | pages 80, 164 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV | not captured | standing | pages 80, 164 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 16, 20, 90, 92, 96, 164 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 16, 20, 90, 92, 96, 164 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 18, 82, 84, 88, 166 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 18, 82, 84, 88, 166 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | pages 167, 216 |
| Hyperactive delirium | peds | 4 mg/kg | IM | not captured | standing | pages 167, 216 |
| RSI induction | adult | 2 mg/kg | IV | not captured | standing | page 191 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | page 191 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 48, 168 |
| Mild to moderate pain | adult | 20–40 mg | IO | not captured | standing | page 168 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 168 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 44, 168 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | pages 44, 168 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 28, 30, 168 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 28, 30, 168 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 28, 30, 168 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 28, 30, 168 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg | IV/IO/IM/IN | not captured | standing | pages 32, 102, 170 |
| Other | peds | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | pages 32, 102, 170 |
| Status epilepticus | adult | 4 mg | IV/IO/IM | not captured | standing | page 170 |
| Status epilepticus | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 170 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 172 |
| Asthma / bronchospasm | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 172 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 76, 172 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | pages 28, 30, 172 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | pages 28, 30, 172 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 174 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 174 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | page 174 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 174 |
| COPD | adult | 125 mg | IV/IO/IM | not captured | standing | page 174 |
| COPD | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 174 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 14, 20, 175 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 14, 20, 175 |
| Procedural sedation | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 32, 175 |
| Status epilepticus | adult | 2 mg | IV/IM/IN | not captured | standing | page 175 |
| Status epilepticus | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 175 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | pages 14, 36, 50, 54, 78, 102, 110, 112, 114, 118, 177 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 14, 36, 50, 54, 78, 102, 110, 112, 114, 118, 177 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | pages 16, 80, 178 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 16, 80, 178 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 36, 37, 86, 87 |
| Other | adult | 1.2 mg | SL | not captured | standing | pages 58, 59 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 8 mg | IV/IO/IM | not captured | standing | pages 14, 36, 50, 98, 110, 112, 114, 181 |
| Nausea / vomiting | adult | 8 mg | ODT | not captured | standing | pages 14, 36, 50, 98, 110, 112, 114, 181 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 14, 36, 50, 98, 110, 112, 114, 181 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | pages 14, 36, 50, 98, 110, 112, 114, 181 |
S–Z Sodium Bicarbonate, Tranexamic Acid2
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 108, 109, 183 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 56, 57, 183 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 56, 57, 183 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 24, 80, 183 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 24, 80, 183 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | pages 102, 184 |
Cite this
Norton Sound Health Corporation, United States EMS Protocol Census. 102 dose entries, effective 2024-05-10.
https://protoquiz.com/census/agencies/norton-sound-health-corporation/
The census is free and not for sale. Only public agencies are named.